• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺嘌呤核苷酸对人ClC-5的细胞内调节

Intracellular regulation of human ClC-5 by adenine nucleotides.

作者信息

Zifarelli Giovanni, Pusch Michael

机构信息

Istituto di Biofisica, Consiglio Nazionale delle Ricerche, Genova, Italy.

出版信息

EMBO Rep. 2009 Oct;10(10):1111-6. doi: 10.1038/embor.2009.159. Epub 2009 Aug 28.

DOI:10.1038/embor.2009.159
PMID:19713962
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2759731/
Abstract

ClC-5, an endosomal Cl(-)/H(+) antiporter that is mutated in Dent disease, is essential for endosomal acidification and re-uptake of small molecular weight proteins in the renal proximal tubule. Eukaryotic chloride channels (CLCs) contain two cytoplasmic CBS domains, motifs present in different proteins, the function of which is still poorly understood. Structural studies have shown that ClC-5 can bind to ATP at the interface between the CBS domains, but so far the potential functional consequences of nucleotide binding to ClC-5 have not been investigated. Here, we show that the direct application of ATP, ADP and AMP in inside-out patch experiments potentiates the current mediated by ClC-5 with similar affinities. The nucleotides increase the probability of ClC-5 to be in an active, transporting state. The residues Tyr 617 and Asp 727, but not Ser 618, are crucial for the potentiation. These results provide a mechanistic and structural framework for the interpretation of nucleotide regulation of a CLC transporter.

摘要

ClC-5是一种在内体性氯离子/氢离子反向转运体,在丹特病中发生突变,对于肾近端小管内体酸化和小分子蛋白质的再摄取至关重要。真核生物氯离子通道(CLCs)包含两个胞质CBS结构域,这些基序存在于不同蛋白质中,其功能仍知之甚少。结构研究表明,ClC-5可在CBS结构域之间的界面处与ATP结合,但迄今为止,尚未研究核苷酸与ClC-5结合的潜在功能后果。在此,我们表明,在inside-out膜片钳实验中直接应用ATP、ADP和AMP可增强由ClC-5介导的电流,且亲和力相似。核苷酸增加了ClC-5处于活性转运状态的概率。残基Tyr 617和Asp 727而非Ser 618对于增强作用至关重要。这些结果为解释CLC转运体的核苷酸调节提供了一个机制和结构框架。

相似文献

1
Intracellular regulation of human ClC-5 by adenine nucleotides.腺嘌呤核苷酸对人ClC-5的细胞内调节
EMBO Rep. 2009 Oct;10(10):1111-6. doi: 10.1038/embor.2009.159. Epub 2009 Aug 28.
2
Nucleotide recognition by the cytoplasmic domain of the human chloride transporter ClC-5.人氯离子转运体ClC-5胞质结构域对核苷酸的识别
Nat Struct Mol Biol. 2007 Jan;14(1):60-7. doi: 10.1038/nsmb1188. Epub 2006 Dec 31.
3
Direct endosomal acidification by the outwardly rectifying CLC-5 Cl(-)/H(+) exchanger.外向整流型 CLC-5 氯离子/氢离子交换器介导的内体直接酸化。
J Physiol. 2010 Jun 15;588(Pt 12):2033-45. doi: 10.1113/jphysiol.2010.188540. Epub 2010 Apr 26.
4
Metabolic energy sensing by mammalian CLC anion/proton exchangers.哺乳动物CLC阴离子/质子交换体对代谢能量的感知
EMBO Rep. 2020 Jun 4;21(6):e47872. doi: 10.15252/embr.201947872. Epub 2020 May 10.
5
Structural basis of adenine nucleotides regulation and neurodegenerative pathology in ClC-3 exchanger.ClC-3 交换器中腺嘌呤核苷酸调节与神经退行性病变的结构基础
Nat Commun. 2024 Aug 6;15(1):6654. doi: 10.1038/s41467-024-50975-w.
6
The muscle chloride channel ClC-1 is not directly regulated by intracellular ATP.肌肉氯离子通道ClC-1不受细胞内ATP的直接调节。
J Gen Physiol. 2008 Feb;131(2):109-16. doi: 10.1085/jgp.200709899.
7
Voltage-dependent electrogenic chloride/proton exchange by endosomal CLC proteins.内体CLC蛋白介导的电压依赖性电致氯化物/质子交换
Nature. 2005 Jul 21;436(7049):424-7. doi: 10.1038/nature03860.
8
Intracellular β-nicotinamide adenine dinucleotide inhibits the skeletal muscle ClC-1 chloride channel.细胞内 β-烟酰胺腺嘌呤二核苷酸抑制骨骼肌 ClC-1 氯离子通道。
J Biol Chem. 2012 Jul 27;287(31):25808-20. doi: 10.1074/jbc.M111.327551. Epub 2012 Jun 11.
9
Functional and structural conservation of CBS domains from CLC chloride channels.氯离子通道(CLC)中CBS结构域的功能与结构保守性
J Physiol. 2004 Jun 1;557(Pt 2):363-78. doi: 10.1113/jphysiol.2003.058453. Epub 2004 Jan 14.
10
Regulation of ClC-2 gating by intracellular ATP.细胞内 ATP 对 ClC-2 门控的调节。
Pflugers Arch. 2013 Oct;465(10):1423-37. doi: 10.1007/s00424-013-1286-0. Epub 2013 May 1.

引用本文的文献

1
Structural basis of adenine nucleotides regulation and neurodegenerative pathology in ClC-3 exchanger.ClC-3 交换器中腺嘌呤核苷酸调节与神经退行性病变的结构基础
Nat Commun. 2024 Aug 6;15(1):6654. doi: 10.1038/s41467-024-50975-w.
2
Characterization of pre-mRNA Splicing Defects Caused by and Mutations and Identification of Novel Variants Associated with Dent Disease.由XX和XX突变引起的前体mRNA剪接缺陷的特征分析以及与丹特病相关的新型变体的鉴定 (你提供的原文中“and”前后应该有具体基因名称等内容缺失,我按格式要求照原样翻译了,你可补充完整信息后继续让我翻译 )
Biomedicines. 2023 Nov 17;11(11):3082. doi: 10.3390/biomedicines11113082.
3
Molecular basis of ClC-6 function and its impairment in human disease.氯离子通道蛋白 6 的功能及其在人类疾病中的作用机制。
Sci Adv. 2023 Oct 13;9(41):eadg4479. doi: 10.1126/sciadv.adg4479.
4
Molecular mechanism underlying regulation of Arabidopsis CLCa transporter by nucleotides and phospholipids.拟南芥 CLCA 转运蛋白受核苷酸和磷脂调节的分子机制。
Nat Commun. 2023 Aug 12;14(1):4879. doi: 10.1038/s41467-023-40624-z.
5
Biophysical Aspects of Neurodegenerative and Neurodevelopmental Disorders Involving Endo-/Lysosomal CLC Cl/H Antiporters.涉及内体/溶酶体CLC氯/氢反向转运体的神经退行性和神经发育障碍的生物物理方面
Life (Basel). 2023 Jun 2;13(6):1317. doi: 10.3390/life13061317.
6
Making a Dent in Dent Disease. dent 病的攻克进展
Function (Oxf). 2020;1(2):zqaa017. doi: 10.1093/function/zqaa017. Epub 2020 Sep 11.
7
Metabolic energy sensing by mammalian CLC anion/proton exchangers.哺乳动物CLC阴离子/质子交换体对代谢能量的感知
EMBO Rep. 2020 Jun 4;21(6):e47872. doi: 10.15252/embr.201947872. Epub 2020 May 10.
8
From protein uptake to Dent disease: An overview of the CLCN5 gene.从蛋白摄取到 Dent 病:CLCN5 基因概述。
Gene. 2020 Jul 15;747:144662. doi: 10.1016/j.gene.2020.144662. Epub 2020 Apr 11.
9
Genetic Analyses in Dent Disease and Characterization of CLCN5 Mutations in Kidney Biopsies.遗传性肾性尿崩症的基因分析及肾活检中 CLCN5 突变的特征。
Int J Mol Sci. 2020 Jan 14;21(2):516. doi: 10.3390/ijms21020516.
10
Cl and H coupling properties and subcellular localizations of wildtype and disease-associated variants of the voltage-gated Cl/H exchanger ClC-5.电压门控氯离子/氢离子交换器 ClC-5 的野生型和与疾病相关变体的 Cl 和 H 耦合特性及亚细胞定位。
J Biol Chem. 2020 Feb 7;295(6):1464-1473. doi: 10.1074/jbc.RA119.011366. Epub 2019 Dec 18.

本文引用的文献

1
Conversion of the 2 Cl(-)/1 H+ antiporter ClC-5 in a NO3(-)/H+ antiporter by a single point mutation.通过单点突变将2Cl⁻/1H⁺反向转运体ClC-5转变为NO₃⁻/H⁺反向转运体。
EMBO J. 2009 Feb 4;28(3):175-82. doi: 10.1038/emboj.2008.284. Epub 2009 Jan 8.
2
ATP inhibition of CLC-1 is controlled by oxidation and reduction.三磷酸腺苷(ATP)对氯离子通道蛋白1(CLC-1)的抑制作用受氧化和还原调控。
J Gen Physiol. 2008 Oct;132(4):421-8. doi: 10.1085/jgp.200810023.
3
The Cl-/H+ antiporter ClC-7 is the primary chloride permeation pathway in lysosomes.氯离子/氢离子逆向转运蛋白ClC-7是溶酶体中主要的氯离子渗透途径。
Nature. 2008 Jun 5;453(7196):788-92. doi: 10.1038/nature06907. Epub 2008 Apr 30.
4
CLC chloride channels and transporters: from genes to protein structure, pathology and physiology.CLC氯离子通道与转运体:从基因到蛋白质结构、病理学与生理学
Crit Rev Biochem Mol Biol. 2008 Jan-Feb;43(1):3-36. doi: 10.1080/10409230701829110.
5
The muscle chloride channel ClC-1 is not directly regulated by intracellular ATP.肌肉氯离子通道ClC-1不受细胞内ATP的直接调节。
J Gen Physiol. 2008 Feb;131(2):109-16. doi: 10.1085/jgp.200709899.
6
Determinants of anion-proton coupling in mammalian endosomal CLC proteins.哺乳动物内体氯离子通道蛋白中阴离子-质子偶联的决定因素。
J Biol Chem. 2008 Feb 15;283(7):4219-27. doi: 10.1074/jbc.M708368200. Epub 2007 Dec 6.
7
CLC chloride channels and transporters: a biophysical and physiological perspective.CLC氯离子通道与转运体:生物物理学与生理学视角
Rev Physiol Biochem Pharmacol. 2007;158:23-76. doi: 10.1007/112_2006_0605.
8
Inhibition of skeletal muscle ClC-1 chloride channels by low intracellular pH and ATP.低细胞内pH值和ATP对骨骼肌ClC-1氯通道的抑制作用。
J Biol Chem. 2007 Nov 9;282(45):32780-91. doi: 10.1074/jbc.M703259200. Epub 2007 Aug 10.
9
Cytoplasmic ATP inhibition of CLC-1 is enhanced by low pH.低pH增强了细胞质ATP对CLC-1的抑制作用。
J Gen Physiol. 2007 Aug;130(2):217-21. doi: 10.1085/jgp.200709817.
10
The structure of the cytoplasmic domain of the chloride channel ClC-Ka reveals a conserved interaction interface.氯离子通道ClC-Ka胞质结构域的结构揭示了一个保守的相互作用界面。
Structure. 2007 Jun;15(6):715-25. doi: 10.1016/j.str.2007.04.013.